These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 1618272)
1. Stereoselective antimuscarinic effects of 3-quinuclidinyl atrolactate and 3-quinuclidinyl xanthene-9-carboxylate. Noronha-Blob L; Sturm B; Lowe V Eur J Pharmacol; 1992 Jan; 211(1):97-103. PubMed ID: 1618272 [TBL] [Abstract][Full Text] [Related]
2. Affinity and selectivity of the optical isomers of 3-quinuclidinyl benzilate and related muscarinic antagonists. Rzeszotarski WJ; McPherson DW; Ferkany JW; Kinnier WJ; Noronha-Blob L; Kirkien-Rzeszotarski A J Med Chem; 1988 Jul; 31(7):1463-6. PubMed ID: 3385735 [TBL] [Abstract][Full Text] [Related]
3. Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes. Waelbroeck M; Lazareno S; Pfaff O; Friebe T; Tastenoy M; Mutschler E; Lambrecht G Br J Pharmacol; 1996 Dec; 119(7):1319-30. PubMed ID: 8968538 [TBL] [Abstract][Full Text] [Related]
4. Enantiomers of oxybutynin: in vitro pharmacological characterization at M1, M2 and M3 muscarinic receptors and in vivo effects on urinary bladder contraction, mydriasis and salivary secretion in guinea pigs. Noronha-Blob L; Kachur JF J Pharmacol Exp Ther; 1991 Feb; 256(2):562-7. PubMed ID: 1993995 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of some 3-(1-azabicyclo[2.2.2]octyl) 3-amino-2-hydroxy-2-phenylpropionates: profile of antimuscarinic efficacy and selectivity. Audia VH; McPherson DW; Weitzberg M; Rzeszotarski WJ; Sturm B; Kachur JF; Abreu M; Kaiser C J Med Chem; 1990 Jan; 33(1):307-10. PubMed ID: 2296026 [TBL] [Abstract][Full Text] [Related]
6. Analgesic, antimuscarinic activity and enantioselectivity of the four isomers of 3-quinuclidinyl tropate as compared with the enantiomers of hyoscyamine. Dei S; Bellucci C; Gualtieri F; Romanelli MN; Scapecchi S; Teodori E; Bartolini A; Ghelardini C Farmaco; 1995 May; 50(5):303-9. PubMed ID: 7626164 [TBL] [Abstract][Full Text] [Related]
7. Stereoselective inhibition of muscarinic receptor subtypes by the enantiomers of hexahydro-difenidol and acetylenic analogues. Feifel R; Wagner-Röder M; Strohmann C; Tacke R; Waelbroeck M; Christophe J; Mutschler E; Lambrecht G Br J Pharmacol; 1990 Mar; 99(3):455-60. PubMed ID: 2331578 [TBL] [Abstract][Full Text] [Related]
8. (+/-)-Terodiline: an M1-selective muscarinic receptor antagonist. In vivo effects at muscarinic receptors mediating urinary bladder contraction, mydriasis and salivary secretion. Noronha-Blob L; Prosser JC; Sturm BL; Lowe VC; Enna SJ Eur J Pharmacol; 1991 Aug; 201(2-3):135-42. PubMed ID: 1724648 [TBL] [Abstract][Full Text] [Related]
9. In vitro characterization of a novel, potent and selective M3 antagonist. Ghelardini C; Bartolini A; Galeotti N; Bellucci C; Dei S; Gualtieri F Life Sci; 1997; 61(13):1217-26. PubMed ID: 9324063 [TBL] [Abstract][Full Text] [Related]
10. Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes. Lambrecht G; Feifel R; Wagner-Röder M; Strohmann C; Zilch H; Tacke R; Waelbroeck M; Christophe J; Boddeke H; Mutschler E Eur J Pharmacol; 1989 Sep; 168(1):71-80. PubMed ID: 2583233 [TBL] [Abstract][Full Text] [Related]
11. M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland. Ikeda K; Kobayashi S; Suzuki M; Miyata K; Takeuchi M; Yamada T; Honda K Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):97-103. PubMed ID: 12122494 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antimuscarinic effects of (-)cis 2,3-dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl-1,5 benzothiazepin-4-(5H)one HCl (BTM-1086) in guinea pig peripheral tissues. Noronha-Blob L; Sturm BL; Lowe VC; Jackson KN; Kachur JF Life Sci; 1990; 46(17):1223-31. PubMed ID: 2338887 [TBL] [Abstract][Full Text] [Related]
13. Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland. Kobayashi F; Yageta Y; Segawa M; Matsuzawa S Arzneimittelforschung; 2007; 57(2):92-100. PubMed ID: 17396619 [TBL] [Abstract][Full Text] [Related]
15. Discovery & development of selective M3 antagonists for clinical use. Alabaster VA Life Sci; 1997; 60(13-14):1053-60. PubMed ID: 9121347 [TBL] [Abstract][Full Text] [Related]
16. Muscarinic receptor selectivities of 3-Quinuclidinyl 8-xanthenecarboxylate (QNX) in rat brain. Gibson RE; Schneidau TA; Gitler M; Zeeberg B; Reba RC Life Sci; 1994; 54(23):1757-65. PubMed ID: 8196489 [TBL] [Abstract][Full Text] [Related]
17. Tolterodine--a new bladder-selective antimuscarinic agent. Nilvebrant L; Andersson KE; Gillberg PG; Stahl M; Sparf B Eur J Pharmacol; 1997 May; 327(2-3):195-207. PubMed ID: 9200560 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists. Gillberg PG; Sundquist S; Nilvebrant L Eur J Pharmacol; 1998 May; 349(2-3):285-92. PubMed ID: 9671109 [TBL] [Abstract][Full Text] [Related]
19. Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo. Hegde SS; Choppin A; Bonhaus D; Briaud S; Loeb M; Moy TM; Loury D; Eglen RM Br J Pharmacol; 1997 Apr; 120(8):1409-18. PubMed ID: 9113359 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the interaction of zamifenacin at muscarinic receptors in vitro. Watson N; Reddy H; Stefanich E; Eglen RM Eur J Pharmacol; 1995 Oct; 285(2):135-42. PubMed ID: 8566131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]